Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00683319 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv16
  2. Interventions: adjuvant therapy (Procedure), carboplatin (Drug), cisplatin (Drug), clinical observation (Other), cognitive assessment (Procedure)… to adjuvant therapy (Procedure), carboplatin (Drug), cisplatin (Drug), cognitive assessment (Procedure), cyclophosphamide (Drug), magnetic…v15
  3. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 10 of 10 sites
    v14
  4. Interventions: adjuvant therapy (Procedure), carboplatin (Drug), cisplatin (Drug), cognitive assessment (Procedure), cyclophosphamide (Drug), magnetic… to adjuvant therapy (Procedure), carboplatin (Drug), cisplatin (Drug), clinical observation (Other), cognitive assessment (Procedure)…v13
  5. Study sites: 7 to 10v12
Show 10 earlier versionsHide 10 earlier versions
  1. 3 versions Re-verified since Feb 6, 2009, no change to tracked fieldsv9-v11
  2. Study sites: 1 to 7v8
  3. 2 versions Re-verified since Oct 17, 2008, no change to tracked fieldsv6-v7
  4. Interventions: adjuvant therapy (Procedure), carboplatin (Drug), cisplatin (Drug), cognitive assessment (Procedure), cyclophosphamide (Drug), magnetic… to adjuvant therapy (Procedure), carboplatin (Drug), cisplatin (Drug), cognitive assessment (Procedure), cyclophosphamide (Drug), magnetic…v5
  5. Re-verified, no change to tracked fieldsv4
  6. Study description revisedv3
  7. Interventions: adjuvant therapy (Procedure), carboplatin (Drug), cisplatin (Drug), cognitive assessment (Procedure), cyclophosphamide (Drug), high-dose… to adjuvant therapy (Procedure), carboplatin (Drug), cisplatin (Drug), cognitive assessment (Procedure), cyclophosphamide (Drug), magnetic…v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
RATIONALE: Gathering information about how young patients with ependymoma respond to standard combination chemotherapy and learning about the long-term effects of this treatment may help doctors plan better treatment. PURPOSE: This phase III trial is observing young patients with ependymoma undergoing standard combination chemotherapy.
Trial Details
NCT Number NCT00683319
Lead Sponsor Children's Cancer and Leukaemia Group
Conditions
(from sponsor)		 Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Long-term Effects Secondary to Cancer Therapy in Children, Ototoxicity
Related terms Central Nervous System Neoplasms, Ototoxicity
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Updated on ClinicalTrials.gov